About BACCH Laboratories
BACCH Laboratories is a private company based in Gainesvile, Florida. It has reported $13,923,736 raised in 11 offerings on Form D since September 2009.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 25, 2024 | Jul 30, 2025 | $810,000of $1.0M target | 14 | $57,857 | Debt, OptionsRule 506(b) | Form D ↗ |
| Jul 25, 2023 | Jul 30, 2025 | $1,810,150of $3.5M target | 27 | $67,043 | Equity, OptionsRule 506(b) | Form D ↗ |
| Jan 25, 2021 | Feb 9, 2021 | $75,000of $200K target | 1 | $75,000 | DebtRule 506(b) | Form D ↗ |
| Nov 8, 2019 | Nov 22, 2019amended Jun 23, 2025 | $2,916,000of $9.0M target | 48 | $60,750 | Simple Agreement for Future EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jan 7, 2019 | Jan 22, 2019 | $2,602,200of $5.2M target | 41 | $63,468 | EquityRule 506(b) | Form D ↗ |
| Apr 16, 2018 | May 1, 2018amended Jun 4, 2018 | $1,500,000fully sold | 29 | $51,724 | Simple Agreement for Future EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Sep 6, 2017 | Sep 20, 2017 | $246,749of $461K target | 21 | $11,750 | EquityRule 506(b) | Form D ↗ |
| Dec 31, 2016 | Jan 13, 2017 | $1,223,958of $1.5M target | 14 | $87,426 | EquityRule 506(b) | Form D ↗ |
| Oct 3, 2011 | Oct 12, 2011 | $743,958of $1.5M target | 12 | $61,997 | Debt, Options06 | Form D ↗ |
| Mar 5, 2010 | Mar 15, 2010amended Feb 11, 2011 | $1,568,426fully sold | 21 | $74,687 | Equity06 | Form D/A ↗3 earlier filings |
| May 20, 2009 | Sep 14, 2009amended Mar 5, 2010 | $427,295of $1.0M target | 7 | $61,042 | Debt, Options06 | Form D/A ↗1 earlier filing |
| Total, 11 offerings | $13,923,736 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on BACCH Laboratories's Form D filed Jul 30, 2025.
GG
Garrett Gleim
Director
JM
James Mentz
Executive officer and director
RA
Richard Allen
Director
BH
Benjamin Hoover
Director
RM
Robert Mentz
Chief Financial Officer
EC
Edgar Choueiri
Executive officer and director
Earlier filings also listed Joseph Cufari (director, last listed Jan 2019), Samuel Caldwell (director, last listed Sep 2017), Peter Phillips (director, last listed Oct 2011), Dan Buffkin (director, last listed Oct 2011), Eric Buffkin (director, last listed Feb 2011) and Alice Sammon (director, last listed Mar 2010).
Sources
- SECBACCH Laboratories, Inc. Form D, filed Nov 22, 2019
- SECBACCH Laboratories, Inc. Form D, filed May 1, 2018
- SECBACCH Laboratories, Inc. Form D/A, filed Oct 29, 2010
- SECBACCH Laboratories, Inc. Form D/A, filed Aug 18, 2010
- SECBACCH Laboratories, Inc. Form D, filed Mar 15, 2010
- SECBACCH Laboratories, Inc. Form D, filed Sep 14, 2009
- SECBACCH Laboratories, Inc. filing history